Nona Scientific, a leading provider of advanced diagnostic solutions for senior living communities, medical offices, and healthcare facilities, is excited to announce the appointment of Robb Chapin as the Chairman of its newly established Advisory Board, effective September 5, 2024. This significant step marks the formal establishment of Nona Scientific’s Advisory Board, which will play a crucial role in guiding the company’s strategic direction and growth.
Nona Scientific has earned a reputation as one of the nation’s top clinical laboratories, offering a wide range of diagnostic services designed to meet the evolving needs of medical practitioners and the senior living community. The company’s commitment to innovation and excellence is reflected in its state-of-the-art laboratory capabilities, which provide accurate and timely diagnostic information critical for effective medical decision-making.
Robb Chapin, Co-founder of Channel Marker Advisors and recently retired vertical CEO at Bridge Investment Group, brings over 30 years of corporate leadership experience to Nona Scientific. His distinguished career includes leadership roles such as Chief Executive Officer and Co-Chief Investment Officer of Bridge Seniors Housing Fund Manager LLC, where he successfully led strategic growth initiatives in the healthcare real estate sector.
“I am honored to take on the role of Chairman for Nona Scientific’s Advisory Board,” said Robb Chapin. “The launch of this board represents a new chapter for Nona Scientific, and I am excited to contribute to its strategic growth. Nona Scientific’s dedication to advancing healthcare through innovative diagnostics is something I am deeply passionate about, and I look forward to working with Mac and the entire team to further elevate the company’s impact in the medical community.”
The establishment of the Advisory Board and the selection of Mr. Chapin highlight Nona Scientific’s dedication to strategic growth and excellence. These are important milestones for Nona Scientific as it aims to expand its presence within the medical community. Mr. Chapin’s extensive experience in senior living and healthcare, along with his leadership at Servant Healthcare Investments, LLC, make him a valuable asset in guiding the company’s expansion efforts. This initiative also sends a strong message to competitors that Nona Scientific is poised for significant growth and will maintain its leadership in the field of diagnostics.
“We are thrilled to not only welcome Robb Chapin as our Advisory Board Chairman but also to officially launch the Advisory Board itself,” said Mac McKellar, CEO of Nona Scientific. “This board will play a vital role in shaping the future of Nona Scientific, and Robb’s strategic vision and expertise make him the ideal leader for this endeavor. His leadership will help us continue our mission to provide exceptional diagnostic services that support healthcare providers in delivering superior patient care.”
